Mind Programme for Women With Breast Cancer (Nationwide Coverage)
MIND(n)
1 other identifier
interventional
153
1 country
1
Brief Summary
The purpose of this research project is to optimize the Mind programme for women with breast cancer, taking into consideration the results from its pilot study, and to testits efficacy and cost-effectiveness through a 3-arm randomized controlled trial
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedFirst Submitted
Initial submission to the registry
January 3, 2024
CompletedFirst Posted
Study publicly available on registry
January 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJanuary 18, 2024
January 1, 2024
1.4 years
January 3, 2024
January 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline cancer-specific quality of life at post-treatment and 6-month follow-up
EORTC QLQ-C30
Baseline, post-treatment (2 months after baseline) and 6-month follow-up
Secondary Outcomes (7)
Change from baseline depressive symptoms and anxiety severity at post-treatment and 6-month follow-up
Baseline, post-treatment (2 months after baseline) and 6-month follow-up
Change from baseline psychological flexibility at post-treatment and 6-month follow-up
Baseline, post-treatment (2 months after baseline) and 6-month follow-up
Change from baseline self-compassion and mindfulness at post-treatment and 6-month follow-up
Baseline, post-treatment (2 months after baseline) and 6-month follow-up
Change from baseline health-related quality of life at post-treatment and 6-month follow-up
Baseline, post-treatment (2 months after baseline) and 6-month follow-up
Change from baseline consumption of resources and costs in breast cancer at post-treatment and 6-month follow-up
Baseline, post-treatment (2 months after baseline) and 6-month follow-up
- +2 more secondary outcomes
Study Arms (3)
Mind programme
EXPERIMENTALThis group will receive the Mind programme. This intervention comprises 8 weekly group sessions, with the duration of 120 minutes each, to be delivered via Zoom. Integration of Acceptance and Commitment Therapy, mindfulness and Compassion Focused Therapy components, adapted to women with breast cancer. All participants will continue on receiving the recommended medical treatment for their clinical diagnosis.
Support group
ACTIVE COMPARATORThis group will receive a 8-week support group intervention (weekly sessions, with the duration of 120 minutes each), via Zoom. All participants will continue on receiving the recommended medical treatment for their clinical diagnosis.
Waiting list (Treatment As Usual / No psychological intervention)
NO INTERVENTIONThis group will receive the (psychological) treatment as usual in Portugal (no treatment), besides the recommended medical treatment for their clinical diagnosis. At the end of this research project, the intervention that proves to be most efficacious will be offered to participants from the waiting list condition.
Interventions
Intervention based on Acceptance and Commitment Therapy, mindfulness, and compassion approaches
This intervention promotes the sharing of cancer-related experiences, active listening, and a sense of community between participants
Eligibility Criteria
You may qualify if:
- age between 18-70;
- primary diagnosis of BC (stages between I and III);
- having a scheduled radiotherapy treatment starting within 2 months, currently undergoing radiotherapy treatment, or having finished radiotherapy treatment no more than 6 months prior, at any hospital in Portugal;
- able to understand and answer to self-report questionnaires in Portuguese;
- having access to a computer or tablet with internet.
You may not qualify if:
- currently undergoing any form of psychological intervention;
- current diagnosis of severe psychiatric illness (psychotic disorder, bipolar disorder, substance abuse, and personality disorder) or suicidal ideation;
- diagnosis of neurological disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Coimbralead
- Fundação para a Ciência e a Tecnologiacollaborator
Study Sites (1)
Center for Research in Neuropsychology and Cognitive and Behavioral Intervention, University of Coimbra
Coimbra, 3000-115 Coimbra, Portugal, Portugal
Related Publications (1)
Trindade IA, Soares A, Skvarc D, Carreiras D, Pereira J, Lourenco O, Sampaio F, de Sousa B, Martins TC, Boaventura P, Marta-Simoes J; Mind Project Team; Moreira H. Efficacy and cost-effectiveness of an ACT and compassion-based intervention for women with breast cancer: study protocol of two randomised controlled trials 1. Trials. 2025 Jan 3;26(1):5. doi: 10.1186/s13063-024-08626-4.
PMID: 39754194DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
January 3, 2024
First Posted
January 18, 2024
Study Start
October 1, 2023
Primary Completion
March 1, 2025
Study Completion
December 1, 2025
Last Updated
January 18, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share